Advertisement

Topics

Excision BioTherapeutics Secures Licenses for CRISPR Gene Editors

10:14 EST 13 Nov 2017 | Contract Pharma

The editors are to be used to treat certain viral infections and infectious diseases

Original Article: Excision BioTherapeutics Secures Licenses for CRISPR Gene Editors

NEXT ARTICLE

More From BioPortfolio on "Excision BioTherapeutics Secures Licenses for CRISPR Gene Editors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...